A multi-centered phase 1 trial to evaluate the memory responses to a single boosting vaccination with ALVAC-HIV vCP205 [HIV vaccine vCP205] in volunteers who have previously received poxvirus-based vaccines

Trial Profile

A multi-centered phase 1 trial to evaluate the memory responses to a single boosting vaccination with ALVAC-HIV vCP205 [HIV vaccine vCP205] in volunteers who have previously received poxvirus-based vaccines

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Sep 2008

At a glance

  • Drugs HIV vaccine vCP205 (Primary)
  • Indications HIV infections
  • Focus Pharmacodynamics; Registrational
  • Most Recent Events

    • 28 Sep 2008 Actual initiation date added as 1 Mar 2000 as reported by ClinicalTrials.gov.
    • 28 Sep 2008 Actual end date changed added as 1 May 2001 as reported by ClinicalTrials.gov.
    • 28 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top